Dr. Charles Drake received both his bachelor's and master's degrees from Rutgers University in New Jersey and went on to the University of Colorado Health Sciences Center in Denver, Colorado for his Ph.D. and M.D. followed by internship, residency and fellowship at Johns Hopkins University.
His clinical interests include prostate cancer, immunology, and vaccine development.
Dr. Freytag received his doctorate in biochemistry from Case Western Reserve Universitys School of Medicine in 1981. Dr. Freytag completed his fellowship in the Pediatric Department of Baylor College of Medicine in Houston, TX, working with genetics. When his fellowship was complete, Dr. Freytag moved on to the University of Michigans Medical School where we worked as an Assistant Professor in the Department of Biological Chemistry.
In 1989 Dr. Freytag began working as a Senior Staff Scientist in the Molecular Biology Research Program for Henry Ford Health System in Detroit, MI. Dr. Freytag currently is Division Head of Research for Henry Fords Radiation Oncology Department. Dr. Freytag is a member of various professional societies including: Phi Kappa Phi Honorary, American Association for the Advancement of Science, American Association for Cancer Research, and American Association for Gene Therapy.
Jonathan W. Simons, MD, is an internationally recognized physician-scientist, oncologist and acclaimed investigator in translational prostate cancer research. Prior to joining the Prostate Cancer Foundation in 2007, he was Distinguished Service Professor of Hematology and Oncology at the Emory University School of Medicine and Professor of Biomedical Engineering and Materials Sciences at the Georgia Institute of Technology. Dr. Simons is the Founding Director of the Winship Cancer Institute at Emory University in Atlanta and Co-Director of the National Cancer Institute Center for Cancer Nanotechnology Excellence at Emory and Georgia Tech.
Dr. Simons received a BA from Princeton University and an MD from The Johns Hopkins University School of Medicine. Before entering medical school he was a Rotary International Postgraduate Fellow in the Humanities at the University of Kent in Canterbury, England, and a Nuffield Foundation Fellow in the Department of Biochemistry at the University of Cambridge. Dr. Simons completed his residency in internal medicine at Massachusetts General Hospital at Harvard Medical School and his fellowship in medical oncology at Johns Hopkins. Dr. Simons has been a funded physician-scientist in prostate cancer by the National Cancer Institute, Department of Defense, PCF and other agencies since 1990. He is also board-certified in internal medicine and medical oncology. He is married to Plum Simons, a breast cancer survivor, and has two sons.